On July 15, 2013, The U.S. Food and Drug Administration issued a press release announcing its decision to allow the marketing of the first medical device based on brain function to help assess attention-deficit/hyperactivity disorder (ADHD) in children and adolescents 6 to 17 years old.
The complete press release may be found at:
Author: WINAHEAD
WINAHEAD is made up of representatives from thirty institutions. Our members are professionals employed by two- and four-year colleges and universities who work directly with students with disabilities to ensure equal access to higher education. WIN indicates the geographic area we represent: Western Iowa and Nebraska. AHEAD is our national parent organization, the Association on Higher Education and Disability.
View all posts by WINAHEAD
WINAHEAD 